Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Fassas

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working PartyChristoph Schmid, Myriam Labopin, Arnon Nagler, et al.
The New England Journal of Medicine|March 10, 2006
Thalidomide and hematopoietic-cell transplantation for multiple myelomaBart Barlogie, Guido Tricot, Elias Anaissie, et al.
Leukemia Research|August 2, 2005
Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemiaTatjana Smilevska, Kostas Stamatopoulos, Maria Samara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2011
Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjectsEvangelia Yannaki, Thalia Papayannopoulou, Erica Jonlin, et al.
Blood|February 28, 2002
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsFenghuang Zhan, Johanna Hardin, Bob Kordsmeier, et al.
Blood|January 18, 2003
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expressionJohn Shaughnessy, Joth Jacobson, Jeff Sawyer, et al.
Blood|September 21, 2006
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlationsKostas Stamatopoulos, Chrysoula Belessi, Carol Moreno, et al.
BMC Medical Genomics|April 15, 2021
Comprehensive tumor molecular profile analysis in clinical practiceMustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, et al.
Lupus|May 4, 2004
Autologous stem cell transplantation for systemic lupus erythematosusDavid Jayne, Jacob Passweg, Alberto Marmont, et al.
Blood|May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyThomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2007
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working PartyChristoph Schmid, Myriam Labopin, Arnon Nagler, et al.
The New England Journal of Medicine|March 10, 2006
Thalidomide and hematopoietic-cell transplantation for multiple myelomaBart Barlogie, Guido Tricot, Elias Anaissie, et al.
Leukemia Research|August 2, 2005
Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemiaTatjana Smilevska, Kostas Stamatopoulos, Maria Samara, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2011
Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjectsEvangelia Yannaki, Thalia Papayannopoulou, Erica Jonlin, et al.
Blood|February 28, 2002
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cellsFenghuang Zhan, Johanna Hardin, Bob Kordsmeier, et al.
Blood|January 18, 2003
Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expressionJohn Shaughnessy, Joth Jacobson, Jeff Sawyer, et al.
Blood|September 21, 2006
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlationsKostas Stamatopoulos, Chrysoula Belessi, Carol Moreno, et al.
BMC Medical Genomics|April 15, 2021
Comprehensive tumor molecular profile analysis in clinical practiceMustafa Özdoğan, Eirini Papadopoulou, Nikolaos Tsoulos, et al.
Lupus|May 4, 2004
Autologous stem cell transplantation for systemic lupus erythematosusDavid Jayne, Jacob Passweg, Alberto Marmont, et al.
Blood|May 21, 2011
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyThomas Daikeler, Myriam Labopin, Massimo Di Gioia, et al.
Pageof 6